Charles Sternberg, Associate Editor11.29.23
Revvity Inc. has launched its EONIS Q system, a CE-IVD declared platform which simplifies and streamlines molecular testing for spinal muscular atrophy (SMA) and severe combined immunodeficiency (SCID) with an innovative workflow, inclusive of the EONIS Q96 instrument, the EONIS SCID-SMA kit and dedicated EONIS EASI software.
“Helping children get a healthier start to life is at the heart of our work and making molecular testing for inherited conditions like SMA and SCID more accessible can help further that aim,” said Petra Furu, general manager of reproductive health at Revvity. “Without compromising quality, speed or test result accuracy, the EONIS Q system is designed to break down some of the common barriers that prevent newborn screening labs from adopting these tests.”
The compact size and smaller physical footprint of the EONIS Q workflow is ideal for all lab sizes, while offering additional benefits for low- and medium-throughput labs, including those without a PCR clean room.
“Helping children get a healthier start to life is at the heart of our work and making molecular testing for inherited conditions like SMA and SCID more accessible can help further that aim,” said Petra Furu, general manager of reproductive health at Revvity. “Without compromising quality, speed or test result accuracy, the EONIS Q system is designed to break down some of the common barriers that prevent newborn screening labs from adopting these tests.”
Fast, Accurate Results and Less Waste
Turnaround time for the EONIS Q workflow from sample-in to result is approximately three hours, and compared to conventional wet qPCR solutions, the system exceeds industry standards in software capability. There are no wash steps required and fewer pipetting and centrifuging steps involved, further reducing hands-on time. Compared to other methods, the EONIS Q system uses fewer consumables and one-time use plasticware, further optimizing resource and cost efficiencies for labs looking to adopt the system.The compact size and smaller physical footprint of the EONIS Q workflow is ideal for all lab sizes, while offering additional benefits for low- and medium-throughput labs, including those without a PCR clean room.